Drug Pricing Reforms Tested In Freewheeling Guangdong Could Be Extended Across China

BEIJING - Pharmaceutical pricing reforms now being tested in the export powerhouse province of Guangdong could be adopted China-wide if they prove successful in balancing the longstanding government goal of making essential drugs affordable for a widening sector of the populace and the newer aim of rewarding innovative drugs with higher price levels